These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 20546441

  • 1. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T.
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [Abstract] [Full Text] [Related]

  • 2. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 May; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

  • 3. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [Abstract] [Full Text] [Related]

  • 4. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, Castro L, Jiménez C, Mendoza JL, Barreiro-de Acosta M, Senent SG, Gomollón F, Calvet X, García-Planella E, Gómez M, Hernández V, Hinojosa J, Mañosa M, Nyssen OP, Gisbert JP.
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [Abstract] [Full Text] [Related]

  • 5. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
    Herrlinger KR, Barthel DN, Schmidt KJ, Büning J, Barthel CS, Wehkamp J, Stange EF, Fellermann K.
    Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769
    [Abstract] [Full Text] [Related]

  • 6. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H, Tanida S, Mizoshita T, Ozeki K, Ebi M, Shimura T, Mori Y, Kataoka H, Kamiya T, Joh T.
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [Abstract] [Full Text] [Related]

  • 7. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F, Orlando A, Scimeca D, Cottone M.
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.
    Yamamoto S, Nakase H, Mikami S, Inoue S, Yoshino T, Takeda Y, Kasahara K, Ueno S, Uza N, Kitamura H, Tamaki H, Matsuura M, Inui K, Chiba T.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):589-97. PubMed ID: 18549460
    [Abstract] [Full Text] [Related]

  • 9. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):747-56. PubMed ID: 17697208
    [Abstract] [Full Text] [Related]

  • 10. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.
    Gastroenterology; 2011 Oct 01; 141(4):1194-201. PubMed ID: 21723220
    [Abstract] [Full Text] [Related]

  • 11. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK, Murray KF.
    J Clin Gastroenterol; 2008 Sep 01; 42(8):875-9. PubMed ID: 18645529
    [Abstract] [Full Text] [Related]

  • 12. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, Boulton-Jones R, Williams A, Church N, Satsangi J, Arnott ID, Scottish Society of Gastroenterology Infliximab Group.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):411-9. PubMed ID: 17635376
    [Abstract] [Full Text] [Related]

  • 13. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):308-14. PubMed ID: 19035973
    [Abstract] [Full Text] [Related]

  • 14. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
    Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.
    Gastroenterology; 2009 Oct 01; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 01; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 16. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
    Dean KE, Hikaka J, Huakau JT, Walmsley RS.
    J Gastroenterol Hepatol; 2012 Mar 01; 27(3):487-92. PubMed ID: 22098019
    [Abstract] [Full Text] [Related]

  • 17. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL, Jewell DP, Travis SP.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1055-60. PubMed ID: 17439506
    [Abstract] [Full Text] [Related]

  • 18. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P.
    Intern Med J; 2014 May 01; 44(5):464-70. PubMed ID: 24612209
    [Abstract] [Full Text] [Related]

  • 19. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb 01; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 20. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 01; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.